EddieFrine: enhanced intro also and updated info to improve readability

2026-02-13T03:25:55Z

enhanced intro also and updated info to improve readability

WikiDwarfBOT: robot: add new article

2023-07-22T09:13:35Z

robot: add new article

New page

{{short description|American healthcare company}}
{{Use dmy dates|date=July 2020}}
{{Infobox company
| name = Elanco Animal Health Incorporated
| logo = Elanco.svg
| type = [[Public company|Public]]
| traded_as = {{ubl|{{NYSE|ELAN}}|[[Russell 1000]] component}}
| founder =
| key_people = {{plainlist|
* R. David Hoover (Chairman)
* Jeff Simmons (CEO)
}}
| industry = [[Pharmaceutical industry|Pharmaceutical (animal)]]
| products = [[Medication|Pharmaceutical drugs (animal)]]
| location = [[Greenfield, Indiana]], U.S.
| revenue = {{increase}} [[US$]]4.765 billion (2021)<ref name=AnnualR2021>{{cite web|url=https://s1.q4cdn.com/466533431/files/doc_financials/2021/ar/Elanco-2021-Annual-Report.pdf|title=2021 Annual Report|work=Elanco|date=December 31, 2021|access-date=17 March 2023}}</ref>
| operating_income = {{increase}} –[[US$]]0.567 billion (2021)<ref name=AnnualR2021 />
| net_income = {{increase}} –[[US$]]0.472 billion (2021)<ref name=AnnualR2021 />
| assets = {{decrease}} [[US$]]16.483 billion (2021)<ref name=AnnualR2021 />
| equity = {{decrease}} [[US$]]7.538 billion (2021)<ref name=AnnualR2021 />
| num_employees = 10,200 (2021)<ref>{{Cite web|url=https://fortune.com/company/elanco-animal-health/|title = Elanco Animal Health Company Profile}}</ref>
| founded =
| website = {{url|elanco.com}}
| footnotes =
}}

'''Elanco Animal Health Incorporated''' is an American [[pharmaceutical]] company which produces [[medicine]]s and [[vaccinations]] for [[pets]] and [[livestock]]. Until 2019, the company was a [[subsidiary]] of [[Eli Lilly and Company]], before being divested. It is the third-largest animal health company in the world.<ref>{{Cite web|url=https://www.insideindianabusiness.com/story/42996955/elanco-moving-global-hq-to-indy|title=Elanco Moving Global HQ to Indy}}</ref>

==History==
The company can trace its roots back to 1953 when Eli Lilly introduced their first antibiotic aimed at veterinary usage with the new plant and animal sciences research being combined into Lilly's Agro-Industrial division led by George Barnes. In the 1960s, the Agro-Industrial division was reorganised launching Elanco Products, short for the parent company name, Eli Lilly and Company.<ref name="auto">{{Cite web|url=https://www.elanco.com/about#history|title=About Elanco | Solutions for Protecting and Enhancing Animal Health|website=www.elanco.com}}</ref>

The 1970s marked a decade of expansion for the business, increasing international operations to 38 global affiliates and 17 manufacturing locations. In the 1980s research moved away from plant sciences and focused on animal health and food quality. In the 1990s another reorganisation led to the company being renamed Elanco Animal Health, focusing solely on animal health.<ref name="auto"/>

In 2007 the business acquired Ivy Animal Health and launched its companion animal business. In 2008 Elanco partnered with Heifer International in order to address food security in developing nations. In 2009 the business launched its data analytics business, Elanco Knowledge Solutions.<ref name="auto"/>

In 2010 the business acquired the European rights to a portfolio of Pfizer Animal Health treatments and an Irish manufacturing site.<ref>{{Cite web|url=https://www.elanco.com/news/press-releases/lilly-to-acquire-european-rights-to-pfizer-animal-health-assets|title=Lilly to Acquire European Rights to Pfizer Animal Health Assets|website=www.elanco.com}}</ref> In 2011, Elanco expanded its footprint in Europe, acquiring [[Johnson & Johnson|Janssen Animal Health]]<ref>{{Cite web|url=https://www.elanco.com/news/press-releases/lilly-makes-irrevocable-offer-to-acquire-janssen-animal-health|title=Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health|website=www.elanco.com}}</ref> and committed to ending hunger for 100,000 families through the Heifer International partnership. In 2012 the business acquired ChemGen Corp.,<ref>{{Cite web |url=https://www.elanco.com/news/press-releases/elanco-acquires-chemgen-leading-enzyme-company |title=Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp. |website=www.elanco.com |date=24 January 2012 |url-status=dead |archive-url=https://web.archive.org/web/20200717134417/https://www.elanco.com/news/press-releases/elanco-acquires-chemgen-leading-enzyme-company |archive-date=17 July 2020 |access-date=17 July 2020 }}</ref> improving their offering in enzyme-based nutrient absorption tools for food-livestock. In 2014, the business acquired Lohmann SE and Lohmann Animal Health for an undisclosed sum<ref>{{Cite web|url=https://www.elanco.com/news/press-releases/elanco-acquires-lohmann-se|title=Elanco Announces Agreement to Acquire Lohmann Animal Health|website=www.elanco.com}}</ref> and [[Novartis|Novartis Animal Health]] for $5.4 billion, the former boosting Elanco's poultry and vaccine business and the latter increasing a broad spectrum of treatments across companion animal, livestock, vaccine and aquaculture offerings. In 2016 Elanco expanded its US-based business, acquiring a suite of vaccines from [[Boehringer Ingelheim|Boehringer Ingelheim Vetmedica]]<ref>{{Cite web|url=https://www.elanco.com/news/press-releases/elanco-closes-on-novartis-animal-health-deal|title=Lilly Finalizes Novartis Animal Health Acquisition|website=www.elanco.com}}</ref> for $885 million.<ref>{{Cite web|url=https://www.elanco.com/news/press-releases/bi-acquisition-release|title=Elanco Animal Health Completes Acquisition of Boehringer Ingelheim Vetmedica's U.S. Feline, Canine and Rabies Vaccines Portfolio|website=www.elanco.com}}</ref><ref>{{Cite web|url=https://www.elanco.com/news/press-releases/acquire-boehringer-ingelheim-vaccines-portfolio|title=Elanco Animal Health Enters Agreement to Acquire Boehringer Ingelheim Vetmedica's U.S. Feline, Canin, and Rabies Vaccines Portfolio|website=www.elanco.com}}</ref>

In 2013, Elanco made a $100M investment in China Animal Healthcare, a leading manufacturer of Animal pharmaceuticals in China. <ref>{{Cite web|url=https://www.feedstuffs.com/story-elanco-invests-in-china-animal-healthcare-52-97134|title=Elanco invests in China Animal Healthcare|website=www.feedstuffs.com|date=12 April 2013 }}</ref>

In 2018, Lilly announced plans to separate its Elanco Animal Health unit from the rest of the business via an [[initial public offering]] on the [[New York Stock Exchange]], with the stock-ticker ''ELAN''. In 2019, the divestiture was completed and Elanco launched on the New York Stock Exchange. In the same year, the US FDA approved [[rabacfosadine]], a first-in-class treatment for canine lymphoma. The business continued to expand is US-business, acquiring Aratana Therapeutics,<ref>{{Cite web|url=https://www.elanco.com/news/press-releases/elanco-announces-agreement-to-acquire-aratana-therapeutics|title=Elanco Announces Agreement to Acquire Aratana Therapeutics; Completes Oncology Development Agreement with VetDC, Creates Specialty Veterinary Business Focus|website=www.elanco.com}}</ref> and its first-in-class treatment for canine osteoarthritis. Elanco also announced it would acquire the developer of vaccines for bacterial disease prevention in food-animals, Prevtec Microbia, Inc.<ref>{{Cite web|url=https://www.elanco.com/news/press-releases/elanco-announces-acquisition-of-prevtec-microbia|title=Elanco Announces Acquisition of Prevtec Microbia Swine Vaccine Company|website=www.elanco.com}}</ref> In the same year the business announced it would acquire Bayer's animal health business for $7.6 billion.<ref>{{Cite news|url=https://uk.reuters.com/article/us-bayer-m-a-elanco-animal-competition-b-idUKKCN24F2NJ|title=Elanco to divest brands, forgo Canadian rights for Bayer's unit deal|newspaper=Reuters|date=14 July 2020|via=uk.reuters.com}}</ref><ref>{{Cite news|url=https://uk.reuters.com/article/us-bayer-animal-health-m-a-elanco-animal-idUKKCN24G2AD|title=Elanco Animal Health wins approval to buy Bayer unit|newspaper=Reuters|date=15 July 2020|via=uk.reuters.com}}</ref><ref>{{Cite web|url=https://www.elanco.com/news/press-releases/elanco-to-acquire-bayer-animal-health-business|title=Elanco Announces Agreement to Acquire Bayer's Animal Health Business|website=www.elanco.com}}</ref>

On December 3, 2020, Elanco announced plans to build a new global headquarters in Indianapolis at the site of the former GM stamping plant, which is located across the White River from the downtown area. The business plans to break ground on the new headquarters in the first half of 2021.<ref>{{Cite web|last=Burris|first=Alexandria|title=Former GM stamping plant will be home to Elanco Animal Health headquarters|url=https://www.indystar.com/story/money/2020/12/04/gm-stamping-plant-site-become-home-elanco-animal-health-hq/3821748001/|access-date=2020-12-05|website=The Indianapolis Star|language=en-US}}</ref>{{Needs update|date=September 2022|reason=Date passed}}

In August 2021, Elanco announced it had closed its acquisition of Kindred Biosciences, enhancing its existing [[biologics]] and [[monoclonal antibody]] pipeline.<ref>{{Cite web|url=https://www.biospace.com/article/releases/elanco-closes-acquisition-of-kindred-biosciences/?s=79|title=Elanco Closes Acquisition of Kindred Biosciences}}</ref>

Elanco's flea and tick collar, branded "Seresto" and manufactured by Bayer Animal Health which was acquired by Elanco in 2020, has been linked to more than 98,000 incidents of poisoning by pesticide, including more than 2,000 pet deaths, according to a 2022 report by a subcommittee of the House Committee on Oversight and Reform. The collars have been banned in Canada.<ref>{{cite web | title=Lawmakers say this flea collar should be recalled after 2,500 pet deaths | website=FOX13 News | date=June 16, 2022 | url=https://www.q13fox.com/news/seresto-flea-tick-collar-pet-deaths-recall-epa | access-date=June 16, 2022}}</ref><ref>{{cite web | last=Novak | first=Matt | title=Seresto Flea Collars Might Be Banned After Lawmakers Grill CEO | website=Gizmodo | date=June 16, 2022 | url=https://gizmodo.com/seresto-flea-collars-might-be-banned-after-lawmakers-gr-1849069454 | access-date=June 16, 2022}}</ref>

==Acquisitions==
{{hidden begin|border=1px #aaa solid|title=Elanco Acquisitions|ta1=center}}
{{Tree list}}
*Elanco Products Company (Established 1954 as a division of Eli Lilly and Company)
**[[Dow AgroSciences|DowElanco]] (Established 1989 as joint venture with [[Dow Chemical]], Sold stake 1999 to Dow)
***Ivy Animal Health<ref>{{cite web | url=http://lilly.mediaroom.com/index.php?s=9042&item=12328 | title=Eli Lilly and Company Announces Acquisition of Ivy Animal Health | publisher=[[PRNewswire]] | date=25 May 2007}}</ref> (Acq 2007)
**[[Pfizer|Pfizer Animal Health]]<ref>{{cite web | url=http://lilly.mediaroom.com/index.php?s=9042&item=6125 | title=Lilly to Acquire European Rights to Pfizer Animal Health Assets | publisher=[[PRNewswire]] | date=8 March 2010}}</ref> (Acq 2010)
**[[Janssen Pharmaceutica|Janssen Pharmaceutica Animal Health]]<ref>{{cite web | url=http://lilly.mediaroom.com/index.php?s=9042&item=30256 | title=Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health | publisher=[[PRNewswire]] | date=14 March 2011}}</ref> (Acq 2011)
**ChemGen Corp<ref>{{cite web | url=http://lilly.mediaroom.com/index.php?s=9042&item=111145 | title=Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp. | publisher=[[PRNewswire]] | date=24 January 2012}}</ref> (Acq 2012)
**Lohmann SE<ref>{{cite web | url=http://lilly.mediaroom.com/index.php?s=9042&item=137283 | title=Elanco Announces Agreement to Acquire Lohmann Animal Health|publisher=[[PRNewswire]] | date=24 February 2014}}</ref> (Acq 2014)
***Lohmann Animal Health (Acq 2014)
**[[Novartis|Novartis Animal Health]] (Acq 2014)
**[[Bayer|Bayer Animal Health]] (Acq 2019)
**Kindred Biosciences (Acq 2021)
{{Tree list/end}}
{{hidden end}}

==References==
{{Reflist}}

==External links==
*{{official|https://www.elanco.com}}
{{Finance links
| name = Elanco Animal Health Incorporated
| symbol = ELAN
| reuters = ELAN.N
| bloomberg = ELAN:US
| sec_cik = ELAN
| yahoo = ELAN
| google = ELAN:NYSE
}}

{{authority control}}

[[Category:Veterinary medicine companies]]
[[Category:Pharmaceutical companies of the United States]]
[[Category:Health care companies based in Indiana]]
[[Category:Companies listed on the New York Stock Exchange]]
[[Category:2018 initial public offerings]]
[[Category:Eli Lilly and Company]]
[[Category:Veterinary medicine in the United States]]
[[Category:Corporate spin-offs]]

Elanco - Revision history

EddieFrine: enhanced intro also and updated info to improve readability

WikiDwarfBOT: robot: add new article